TMCnet News
Research and Markets: 2015 Strategies in the UK Tumor Marker Testing MarketResearch and Markets (http://www.researchandmarkets.com/research/hrf454/2015_strategies) has announced the addition of the "2015 Strategies in the UK Tumor Marker Testing Market" report to their offering. Comprehensive 575-page analysis of the UK tumor marker testing market. Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Mortality statistics and scientific views on the etiology of major types of cancr, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. Five-year test volume and sales forecasts over for 40 tumor marker performed in UK hospitals, commercial laboratories and physician offices. Placements and installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. Sales and market shares of leading suppliers. Emerging diagnostic technologies and their potential market applications. Product development opportunities. Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. For more information visit http://www.researchandmarkets.com/research/hrf454/2015_strategies
View source version on businesswire.com: http://www.businesswire.com/news/home/20150529005863/en/ |
